CEO LEADERSHIP SERIES

ASHTON TWEED'S CEO INTERVIEWS

August 21, 2017
Debbie Hart

CEO Leadership Series: Debbie Hart, President & CEO, BioNJ

SUPPORTING INNOVATION IN A RAPIDLY EVOLVING INDUSTRY In 1994, Debbie Hart became the founding president of BioNJ, a trade group that initially represented approximately 30 biotech […]
July 7, 2017
Jim Caruso

CEO Leadership Series: James Caruso, President & CEO, Cellectar Biosciences

HOW TO INFLUENCE A COMPANY’S CULTURE AND WHY IT MATTERS In his 27 years as a biotech and pharmaceutical professional, James Caruso has held key executive […]
May 19, 2017
Betsy Hanna

CEO Leadership Series: Elizabeth Hanna, President, Human Health, & Chief Operating Officer, Origin

WHY STRONG PLANNING AND EXECUTION SKILLS ARE VITAL TO EARLY-STAGE COMPANIES Elizabeth “Betsy” Hanna spent much of her career with large organizations – including pharma giants […]
April 7, 2017
Christopher Schaber

CEO Leadership Series: Christopher J. Schaber, PhD, President & CEO, Soligenix, Inc.

February 27, 2017
Cynthia Schwalm

CEO Leadership Series: Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen

HOW TO MAKE TOUGH DECISIONS AND HELP OTHERS SUCCEED In the three years since Cynthia Schwalm joined Ipsen’s North America operations, she’s handled the enviable challenge […]
January 3, 2017

CEO Leadership Series: Elizabeth G. Posillico, PhD, President & CEO, Elusys Therapeutics, Inc.

HOW TO TRANSITION FROM AN R&D TO CLINICAL-STAGE CULTURE During the 11 years that Dr. Elizabeth G. “Tibby” Posillico has been President and CEO of Elusys Therapeutics, […]
November 17, 2016
Philip M. Sass

CEO Leadership Series: Philip M. Sass, Chairman, President & CEO, Liquid Biotech USA, Inc.

INVESTING IN THE FUTURE OF CANCER TREATMENT After co-founding and building Morphotek, Inc., a biotech company that specializes in developing biologics for the treatment of oncology, infectious […]
September 26, 2016

CEO Leadership Series: Scott Jackson, Former CEO, Celator Pharmaceuticals, Inc.

HOW WHEN PERSEVERANCE AND PASSION FINALLY PAY OFF When Scott Jackson became CEO of Celator Pharmaceuticals, Inc. more than eight years ago, a new treatment for […]
August 19, 2016
Gur Roshwalb, M.D.

CEO Leadership Series: Gur Roshwalb, MD, CEO, Akari Therapeutics Plc

HOW A MERGER JUMP-STARTED A PROMISING DRUG’S DEVELOPMENT Gur Roshwalb, M.D., isn’t afraid of a challenge. When Dr. Roshwalb, CEO of Akari Therapeutics Plc, saw a […]
July 11, 2016
Francois Nader, MD, MBA

CEO Leadership Series: Francois Nader, MD, Chairman, Acceleron Pharma Inc.

WHY CULTURE IS THE KEY TO A COMPANY’S SUCCESS Dr. Francois Nader knows something about the importance of embracing a culture, whether it’s on a personal […]
May 31, 2016

CEO Leadership Series: Kenneth L. Londoner, Executive Chairman, BioSig Technologies, Inc.

AN ENTREPRENEURIAL PATHWAY TO LEADERSHIP With an investment and business development background, Kenneth L. Londoner’s career is proof no set or predictable path to running a […]
April 14, 2016
Francois R. Martelet, Chief Executive Officer, NetScientific Plc

CEO Leadership Series: Francois R. Martelet, Chief Executive Officer, NetScientific Plc

TAKING THE REINS OF A HEALTHCARE TECHNOLOGY INVESTMENT COMPANY French by birth, based in London and doing business in the San Francisco Bay-area biotech community, Dr. […]
March 17, 2016
Ivan R. Sabel, Chief Executive Officer, Orthotic Holdings Inc.

CEO Leadership Series: Ivan R. Sabel, Chief Executive Officer, Orthotic Holdings Inc.

PASSION FOR PATIENT CARE HELPS BUILD BUSINESS As the CEO of Orthotic Holdings Inc. (OHI), Ivan R. Sabel draws on his experience as both a practitioner […]
January 29, 2016
Kathleen P. DeLawrence, Chief Operating Officer, Ability Prosthetics & Orthotics, Inc.

CEO Leadership Series: Kathleen P. DeLawrence, Chief Operating Officer, Ability Prosthetics & Orthotics, Inc.

MAKING CONNECTIONS AND SEIZING OPPORTUNITIES Kathleen P. DeLawrence, Chief Operating Officer of Ability Prosthetics & Orthotics, Inc., has an impressive breadth of experience in the pharmaceutical, […]
December 9, 2015
Graham G. Lumsden, CEO, Motif Bio plc

CEO Leadership Series: Graham G. Lumsden, CEO, Motif Bio plc

AFTER DECADES AT MERCK, A NEW ENTREPRENEURIAL BEGINNING After 26 years at Merck & Co. Inc., Graham G. Lumsden was evaluating his career options. He decided […]
portrait of a businessman and a businesswoman leader

ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?

CONTACT US TO DISCUSS AN INTERVIEW:

Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441

Ashton Tweed, Ltd.
565 E. Swedesford Rd.
Suite 214
Wayne, PA 19087